An update on the safety of insulin-GLP-1 receptor agonist combinations in type 2 diabetes mellitus / Novodvorsky P., Haluzik M.. Expert opinion on drug safety. - 2022 Mar;21(3):349-361 [Dokument nie je vo fonde knižnice]
This site uses cookies to make them easier to browse. Learn more about
how we use cookies.